Available Technologies

# of Displayed Technologies: 2 / 2

Categories

Cbl-b Inhibition as a Therapeutic Approach to Disseminated Candidiasis
TS-037695 — Disseminated C. albicans infection in patients who have a weakened immune system is life threatening and causes 40% of bloodstream infections (candidemia) in hospitals. Despite the availability of several anti­fungal drugs, invasive candidiasis still has a high mortality rate ranging from 19-4…
  • College: College of Medicine (COM)
  • Inventors: Zhang, Jian; Rappleye, Chad
  • Licensing Officer: Davis, Stewart
Attenuated Vaccines for Human Respiratory Viruses (hMVP, hRSV, hPIV3)
TS-014854 — A live attenuated vaccine that targets viral genome replication, virus assembly, and budding.
Paramyxoviruses are the leading causative agents of acute viral respiratory tract infections. Among the paramyxoviruses, human metapneumovirus (hMPV), human respiratory syncytial virus (hRSV), and human parainfluenza virus type 3 (hPIV3) account for more than 70% of acute viral respiratory disease…
  • College: College of Food, Agricultural, and Environmental Sciences (CFAES)
  • Inventors: Li, Jianrong; Zhang, Yu
  • Licensing Officer: Dahlman, Jason "Jay"

Loading icon